Type | Public | |
Founded | 1998 | |
HQ | HK | Map |
Website | jacobsonpharma.com |
HKD | |
---|---|
Revenue (H1, 2022) | 750.4m |
Gross profit (H1, 2022) | 387.1m |
Gross profit margin (H1, 2022), % | 51.6% |
Net income (H1, 2022) | 82.9m |
EBITDA (H1, 2022) | 202.4m |
EBIT (H1, 2022) | 104.3m |
Market capitalization (22-Jul-2022) | 1.3b |
Closing stock price (22-Jul-2022) | 0.7 |
Cash (30-Sept-2021) | 537.1m |
EV | 2.2b |
HKD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Revenue | 1.5b | 1.7b | 1.8b | 1.5b |
Cost of goods sold | (816.3m) | (897.9m) | (901.9m) | (704.6m) |
Gross profit | 734.8m | 812.7m | 879.1m | 849.0m |
Gross profit Margin, % | 47% | 48% | 50% | 58% |
HKD | H1, 2019 | H1, 2020 | H1, 2021 | H1, 2022 |
---|---|---|---|---|
Revenue | 816.3m | 871.7m | 709.6m | 750.4m |
Cost of goods sold | (436.4m) | (427.7m) | (353.4m) | (380.0m) |
Gross profit | 381.2m | 459.0m | 422.6m | 387.1m |
Gross profit Margin, % | 47% | 53% | 60% | 52% |
HKD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Cash | 656.7m | 629.8m | 418.0m | 480.4m |
Accounts Receivable | 197.4m | 214.2m | 199.9m | 261.0m |
Prepaid Expenses | 13.8m | 3.0m | 16.8m | 6.5m |
Inventories | 316.3m | 333.8m | 371.5m | 356.2m |
HKD | H1, 2019 | H1, 2020 | H1, 2021 | H1, 2022 |
---|---|---|---|---|
Cash | 791.4m | 718.2m | 479.5m | 537.1m |
Accounts Receivable | 204.8m | 199.9m | 207.8m | 299.0m |
Prepaid Expenses | 8.3m | 719.0k | 13.7m | 5.6m |
Inventories | 324.9m | 375.7m | 385.8m | 319.6m |
HKD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 |
---|---|---|---|---|
Net Income | 251.2m | 315.1m | 263.5m | 220.6m |
Depreciation and Amortization | 112.4m | 115.9m | 170.8m | 191.7m |
Inventories | (38.9m) | (17.5m) | (51.7m) | 20.9m |
Accounts Payable | (13.2m) | 6.8m | (391.0k) | 17.7m |
HKD | H1, 2019 | H1, 2020 | H1, 2021 | H1, 2022 |
---|
HKD | FY, 2018 |
---|---|
Debt/Equity | 0.7 x |
Debt/Assets | 0.4 x |
Financial Leverage | 1.8 x |
Jacobson Pharma revenue breakdown by business segment: 71.8% from GENERIC DRUGS, 27.2% from PROPRIETARY CHINESE MEDICINES and 1.0% from Other
Jacobson Pharma revenue breakdown by geographic segment: 89.9% from HONG KONG and 10.1% from Other
When was Jacobson Pharma founded?
Jacobson Pharma was founded in 1998.
Who are Jacobson Pharma key executives?
Jacobson Pharma's key executives are Yim Chun Leung, Pun Yue Wai and Young Chun Man.
How many employees does Jacobson Pharma have?
Jacobson Pharma has 1,723 employees.
What is Jacobson Pharma revenue?
Latest Jacobson Pharma annual revenue is $1.5 b.
What is Jacobson Pharma revenue per employee?
Latest Jacobson Pharma revenue per employee is $847.4 k.
Who are Jacobson Pharma competitors?
Competitors of Jacobson Pharma include Strides Pharma, YiChang HEC ChangJiang Pharmaceutical and Cipla.
Where are Jacobson Pharma offices?
Jacobson Pharma has offices in Guangzhou Shi and Singapore.
How many offices does Jacobson Pharma have?
Jacobson Pharma has 5 offices.
Receive alerts for 300+ data fields across thousands of companies